KA-672 Dr Wilmar Schwabe GmbH & Co

IDrugs

Volumn 1, Issue 1, 1998, Pages 136-140

  Mucke, Hermann ^a  

^a Sanochemia   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0000915218     PISSN: 13697056     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Neurologic Drugs. DRUG NEWS PERSPECT 1995 8 1 47-48
2. KA-672.HCL: A new orally active antldementia agent. Klusa V, Germane S, Chatterjee SS, Noeldner M EUR J PHARM SCI 1994 2 1-2
3. Willmar Schwabe GmbH COMPANY COMMUNICATION 1997 August 08
4. Anseculin hydrochloride. DRUGS FUTURE 1996 21 8 779-781
5. Effects of anseculin on some excitatory amino acid-induced phenomena. Chatterjee SS, Noldner M PHARMACOL TOXICOL 1997 80 Suppl 1 abs 16
6. Neurotrophic effects of KA-672 HCI on cultured embryonic septal cells. Klimaviciusa L, Chatterjee SS, Noldner M, Svirskis S, Klusa V PHARMACOL TOXICOL 1997 80 suppl 1 abs28
7. Modulation of neurotransmitter by Anseculin. Noldner M, Chatterjee SS PHARMACOL TOXICOL 1997 80 suppl 1 abs38
8. Influence of KA-672.HCI on the NMDA-induced neurotoxicity in mice: the contents of the brain monoamines. Skujins A, Svirskis M, Noldner M, Chatterjee SS, Klusa V PHARMACOL TOXICOL 1997 80 suppl 1 abs48
9. Anseculin, a neuronal activator against dementia: tolerability, safety, preliminary pharmacokinetics in male and female volunteers. Sourgens H, Horr R, Steinbrede H, Derendorf H PHARMACOL TOXICOL 1997 80 suppl 1 abs50
10. Therapeutic approach in dementia. Trabucchi M, Bianchetti A RIV PSICHIATR 1997 32 4 SUPPL 20-26
11. [Treatment of dementia with Tacrine], THERAPIE DEMENTIELLER ERKRANKUNGEN MIT TACRIN. Gastpar M FORTSCHR FORTBILD MED 1997 21-451 -458+495
12. Benzopyranones, a method for producing them and uses thereof. Chatterjee SS, Noeldner M, Hauer H, Kock E US PATENT 1995, June 27 Dr W Schwabe GmbH & Co, Germany.
13. 450 activities in primary hepatocyte cultures derived from rats, hamsters and monkeys. Mennes WC, van Holsteijn CW, Timmerman A, Noordhoek J, Blaauboer BJ BIOCHEM PHARMACOL 1991 41 8 1203-1208
14. Dr Wilmar Schwabe GmbH & Co COMPANY COMMUNICATION 1998 March 6
15. KA-672 HCI: A novel anticholinesterase inhibitor with no effects on arylacylamidase or butyrylcholinesterase. Noeldner M, Chatterjee SS 9TH INT SYMPOSIUM CHOLINERGIC MECHANISMS 19957-10 June